Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site urticaria
Clinical narrative: Generalized prickle sensation; Localized injection site urticaria; flushing; profuse sweating; arm pain; loss of motion; This is a spontaneous report from a contactable other healthcare professional (patient). A 45-year female patient received BNT162B2 (lot number: EM9899) first dose on 17Dec2020 20:00 Intramuscular on right arm at single dose for COVID-19 immunization. Medical history included Asthma, Sulfa and Reglan allergies, Possible Covid 19 in Mar2020, Extensive cardia workup months following Dx with recurrent pericarditis, Non specific T wave abnormality on colchicinent Pepcid. Previous pericarditis Oct2016. Concomitant medications included Valsartan, amlodipine besilate, spironolactone, formoterol fumarate, mometasone furoate (DULERA), siugular, pristing, clonazepam, pramipexole dihydrochloride (MIRAPEX), Pepcid, colchicine (for pericardins). Patient had Flushing, Sweating (Perfuse sweating head and neck), Pain in arm and Mobility decreased (Moderate arm pain and loss of motion due to pain after both injections), Symptoms occurred 3-4 days after 1st vaccine and lasted 2.5 weeks. Organ involvement: Multiorgan Involvement, Respiratory, Bilateral wheeze/bronchospasm, Upper airway sweeling, Respiratory distress, Tachypnoea, Increased use of accessory respiratory muscles, Recession, Cyanosis, Grunting, Dry cough, Hoarse voice, Difficulty breathing (without wheeze or stridor), Sensation of throat closure, Sneezing, Rhinorrhea, Cardiovascular, Measured hypotension, Shock, Tachycardia, Capillary refill time > 3 sec, Reduced central pulse volume, Decreased level of consciousness, Loss of consciousness, Dermatological/Mucosal, Generalized Urticaria, Generalized erythema, Angioedema, Generalized pruritus with skin rash, Generalized pruritus without skin rash, Red and itchy eyes, Nausea, Vomiting, all were No. Generalized prickle sensation and Localized injection site urticaria were yes. The patient did not require medical intervention, the patient was not seen in the Emergency Department, not hospitalized, not admitted to an intensive care. The event did not require the initiation of new medication or other treatment or procedure. There is not a previous history of any allergies, does the patient take (or have readily available) any specific medication related to this. patient did not receive any recent vaccines for any other conditions prior to the event being reported, patient did not receive any recent vaccines for SARS-CoV2 other than Pfizer-BioNTech COVID-19 Vaccine prior to the event being reported, patient had not received any other vaccines around the time of Pfizer-BioNTech COVID-19 Vaccine vaccination. None of the event above consideration serious due to begin life threating, or due to persistent or significant disability/incapacity or any other reason, if yes note below which event and serious criteria. patient not decreased. No treatment required. None of the AEs require a visit to: Physician office. No culture performed. No anti pyretic use. The outcome of the events was recovered.   No follow-up attempts are needed. No further information is expected.